The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...
When most people think about this question their minds turn to lottery winners. Does all that money really make them happy, they wonder with at least as much envy as curiosity. But what about the ...